7777 Stock Overview
3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
3-D Matrix, Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥119.00 |
| 52 Week High | JP¥207.00 |
| 52 Week Low | JP¥101.00 |
| Beta | 0.62 |
| 1 Month Change | -9.16% |
| 3 Month Change | -8.46% |
| 1 Year Change | -32.77% |
| 3 Year Change | -54.23% |
| 5 Year Change | -83.68% |
| Change since IPO | -63.52% |
Recent News & Updates
Shareholder Returns
| 7777 | JP Biotechs | JP Market | |
|---|---|---|---|
| 7D | -7.8% | -3.0% | 0.6% |
| 1Y | -32.8% | -28.7% | 32.7% |
Return vs Industry: 7777 underperformed the JP Biotechs industry which returned -28.7% over the past year.
Return vs Market: 7777 underperformed the JP Market which returned 32.7% over the past year.
Price Volatility
| 7777 volatility | |
|---|---|
| 7777 Average Weekly Movement | 7.6% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 8.2% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 7777 has not had significant price volatility in the past 3 months.
Volatility Over Time: 7777's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 108 | Jun Okada | www.3d-matrix.co.jp |
3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.
3-D Matrix, Ltd. Fundamentals Summary
| 7777 fundamental statistics | |
|---|---|
| Market cap | JP¥9.68b |
| Earnings (TTM) | -JP¥1.06b |
| Revenue (TTM) | JP¥3.74b |
2.5x
P/S Ratio-8.9x
P/E RatioIs 7777 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7777 income statement (TTM) | |
|---|---|
| Revenue | JP¥3.74b |
| Cost of Revenue | JP¥1.35b |
| Gross Profit | JP¥2.40b |
| Other Expenses | JP¥3.46b |
| Earnings | -JP¥1.06b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -13.38 |
| Gross Margin | 64.04% |
| Net Profit Margin | -28.40% |
| Debt/Equity Ratio | 679.6% |
How did 7777 perform over the long term?
See historical performance and comparison